259 related articles for article (PubMed ID: 23974201)
1. Pediatric acute myeloid leukemia with t(8;16)(p11;p13), a distinct clinical and biological entity: a collaborative study by the International-Berlin-Frankfurt-Munster AML-study group.
Coenen EA; Zwaan CM; Reinhardt D; Harrison CJ; Haas OA; de Haas V; Mihál V; De Moerloose B; Jeison M; Rubnitz JE; Tomizawa D; Johnston D; Alonzo TA; Hasle H; Auvrignon A; Dworzak M; Pession A; van der Velden VH; Swansbury J; Wong KF; Terui K; Savasan S; Winstanley M; Vaitkeviciene G; Zimmermann M; Pieters R; van den Heuvel-Eibrink MM
Blood; 2013 Oct; 122(15):2704-13. PubMed ID: 23974201
[TBL] [Abstract][Full Text] [Related]
2. Prognostic impact of t(16;21)(p11;q22) and t(16;21)(q24;q22) in pediatric AML: a retrospective study by the I-BFM Study Group.
Noort S; Zimmermann M; Reinhardt D; Cuccuini W; Pigazzi M; Smith J; Ries RE; Alonzo TA; Hirsch B; Tomizawa D; Locatelli F; Gruber TA; Raimondi S; Sonneveld E; Cheuk DK; Dworzak M; Stary J; Abrahamsson J; Arad-Cohen N; Czogala M; De Moerloose B; Hasle H; Meshinchi S; van den Heuvel-Eibrink M; Zwaan CM
Blood; 2018 Oct; 132(15):1584-1592. PubMed ID: 30150206
[TBL] [Abstract][Full Text] [Related]
3. AML with translocation t(8;16)(p11;p13) demonstrates unique cytomorphological, cytogenetic, molecular and prognostic features.
Haferlach T; Kohlmann A; Klein HU; Ruckert C; Dugas M; Williams PM; Kern W; Schnittger S; Bacher U; Löffler H; Haferlach C
Leukemia; 2009 May; 23(5):934-43. PubMed ID: 19194466
[TBL] [Abstract][Full Text] [Related]
4. Characteristics and outcome of patients with acute myeloid leukaemia and t(8;16)(p11;p13): results from an International Collaborative Study.
Kayser S; Hills RK; Langova R; Kramer M; Guijarro F; Sustkova Z; Estey EH; Shaw CM; Ráčil Z; Mayer J; Zak P; Baer MR; Brunner AM; Szotkowski T; Cetkovsky P; Grimwade D; Walter RB; Burnett AK; Ho AD; Ehninger G; Müller-Tidow C; Platzbecker U; Thiede C; Röllig C; Schulz A; Warsow G; Brors B; Esteve J; Russell NH; Schlenk RF; Levis MJ
Br J Haematol; 2021 Mar; 192(5):832-842. PubMed ID: 33529373
[TBL] [Abstract][Full Text] [Related]
5. Acute myeloid leukemia with t(8;16)(p11.2;p13.3)/KAT6A-CREBBP in adults.
Xie W; Hu S; Xu J; Chen Z; Medeiros LJ; Tang G
Ann Hematol; 2019 May; 98(5):1149-1157. PubMed ID: 30759270
[TBL] [Abstract][Full Text] [Related]
6. Prognosis of patients with t(8;16)(p11;p13) acute myeloid leukemia.
Brown T; Swansbury J; Taj MM
Leuk Lymphoma; 2012 Feb; 53(2):338-41. PubMed ID: 21846182
[No Abstract] [Full Text] [Related]
7. Acute myeloid leukemia with translocation (8;16)(p11;p13) and MYST3-CREBBP rearrangement harbors a distinctive microRNA signature targeting RET proto-oncogene.
Díaz-Beyá M; Navarro A; Ferrer G; Díaz T; Gel B; Camós M; Pratcorona M; Torrebadell M; Rozman M; Colomer D; Monzo M; Esteve J
Leukemia; 2013 Mar; 27(3):595-603. PubMed ID: 23022987
[TBL] [Abstract][Full Text] [Related]
8. Translocation t(8;16)(p11;p13) in acute non-lymphocytic leukemia: report on two new cases and review of the literature.
Velloso ER; Mecucci C; Michaux L; Van Orshoven A; Stul M; Boogaerts M; Bosly A; Cassiman JJ; Van Den Berghe H
Leuk Lymphoma; 1996 Mar; 21(1-2):137-42. PubMed ID: 8907281
[TBL] [Abstract][Full Text] [Related]
9. A distinct subtype of M4/M5 acute myeloblastic leukemia (AML) associated with t(8:16)(p11:p13), in a patient with the variant t(8:19)(p11:q13)--case report and review of the literature.
Stark B; Resnitzky P; Jeison M; Luria D; Blau O; Avigad S; Shaft D; Kodman Y; Gobuzov R; Ash S
Leuk Res; 1995 Jun; 19(6):367-79. PubMed ID: 7596149
[TBL] [Abstract][Full Text] [Related]
10. The clinical utility of genetic testing for t(8;16)(p11;p13) in congenital acute myeloid leukemia.
Daifu T; Kato I; Kozuki K; Umeda K; Hiramatsu H; Watanabe K; Kamiya I; Taki T; Nakahata T; Heike T; Adachi S
J Pediatr Hematol Oncol; 2014 Jul; 36(5):e325-7. PubMed ID: 24390445
[TBL] [Abstract][Full Text] [Related]
11. Clinical Impact of Additional Cytogenetic Aberrations, cKIT and RAS Mutations, and Treatment Elements in Pediatric t(8;21)-AML: Results From an International Retrospective Study by the International Berlin-Frankfurt-Münster Study Group.
Klein K; Kaspers G; Harrison CJ; Beverloo HB; Reedijk A; Bongers M; Cloos J; Pession A; Reinhardt D; Zimmerman M; Creutzig U; Dworzak M; Alonzo T; Johnston D; Hirsch B; Zapotocky M; De Moerloose B; Fynn A; Lee V; Taga T; Tawa A; Auvrignon A; Zeller B; Forestier E; Salgado C; Balwierz W; Popa A; Rubnitz J; Raimondi S; Gibson B
J Clin Oncol; 2015 Dec; 33(36):4247-58. PubMed ID: 26573082
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of specific chromosomal aberrations in a large group of pediatric patients with acute myeloid leukemia treated uniformly according to trial AML-BFM 98.
von Neuhoff C; Reinhardt D; Sander A; Zimmermann M; Bradtke J; Betts DR; Zemanova Z; Stary J; Bourquin JP; Haas OA; Dworzak MN; Creutzig U
J Clin Oncol; 2010 Jun; 28(16):2682-9. PubMed ID: 20439630
[TBL] [Abstract][Full Text] [Related]
13. Translocation (8;18;16)(p11;q21;p13). A new variant of t(8;16)(p11;p13) in acute monoblastic leukemia: case report and review of the literature.
Mo J; Lampkin B; Perentesis J; Poole L; Bao L
Cancer Genet Cytogenet; 2006 Feb; 165(1):75-8. PubMed ID: 16490600
[TBL] [Abstract][Full Text] [Related]
14. A new chromosomal three-way rearrangement involving MLL masked by a t(9;19)(p11;p13) in an infant with acute myeloid leukemia.
de Jesus Marques-Salles T; Liehr T; Mkrtchyan H; Raimondi SC; Tavares de Souza M; de Figueiredo AF; Rouxinol S; Jordy Macedo FC; Abdelhay E; Santos N; Macedo Silva ML
Cancer Genet Cytogenet; 2009 Feb; 189(1):59-62. PubMed ID: 19167614
[TBL] [Abstract][Full Text] [Related]
15. FISH identifies a KAT6A/CREBBP fusion caused by a cryptic insertional t(8;16) in a case of spontaneously remitting congenital acute myeloid leukemia with a normal karyotype.
Barrett R; Morash B; Roback D; Pambrun C; Marfleet L; Ketterling RP; Harrison K; Berman JN
Pediatr Blood Cancer; 2017 Aug; 64(8):. PubMed ID: 28097792
[TBL] [Abstract][Full Text] [Related]
16. [Clinical and experimental studies of childhood acute myeloid leukemia with 11q23/MLL rearrangements].
He YX; Xue YQ; Wang HY; Shao XJ; Pan JL; Xu J; Yang NC; Ji ZH; Huang YP; Hu SY
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Dec; 29(6):677-82. PubMed ID: 23225048
[TBL] [Abstract][Full Text] [Related]
17. Deregulated expression of EVI1 defines a poor prognostic subset of MLL-rearranged acute myeloid leukemias: a study of the German-Austrian Acute Myeloid Leukemia Study Group and the Dutch-Belgian-Swiss HOVON/SAKK Cooperative Group.
Gröschel S; Schlenk RF; Engelmann J; Rockova V; Teleanu V; Kühn MW; Eiwen K; Erpelinck C; Havermans M; Lübbert M; Germing U; Schmidt-Wolf IG; Beverloo HB; Schuurhuis GJ; Ossenkoppele GJ; Schlegelberger B; Verdonck LF; Vellenga E; Verhoef G; Vandenberghe P; Pabst T; Bargetzi M; Krauter J; Ganser A; Valk PJ; Löwenberg B; Döhner K; Döhner H; Delwel R
J Clin Oncol; 2013 Jan; 31(1):95-103. PubMed ID: 23008312
[TBL] [Abstract][Full Text] [Related]
18. [Clinical characteristics of acute myeloid leukemia with t (16;21) (p11;q22):nine cases report and literature review].
Ouyang M; Xu LP; Wang Y; Zhu HH; Qin YZ; Lai YY; Liu YR; Jiang B; Huang XJ; Jiang H
Zhonghua Xue Ye Xue Za Zhi; 2016 Mar; 37(3):210-5. PubMed ID: 27033758
[TBL] [Abstract][Full Text] [Related]
19. RT-PCR analysis of the MOZ-CBP and CBP-MOZ chimeric transcripts in acute myeloid leukemias with t(8;16)(p11;p13).
Panagopoulos I; Isaksson M; Lindvall C; Björkholm M; Ahlgren T; Fioretos T; Heim S; Mitelman F; Johansson B
Genes Chromosomes Cancer; 2000 Aug; 28(4):415-24. PubMed ID: 10862050
[TBL] [Abstract][Full Text] [Related]
20. Gene expression profiling of acute myeloid leukemia with translocation t(8;16)(p11;p13) and MYST3-CREBBP rearrangement reveals a distinctive signature with a specific pattern of HOX gene expression.
Camós M; Esteve J; Jares P; Colomer D; Rozman M; Villamor N; Costa D; Carrió A; Nomdedéu J; Montserrat E; Campo E
Cancer Res; 2006 Jul; 66(14):6947-54. PubMed ID: 16849538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]